Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).
LSP has closed its LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.
Pest control specialist Biotalys NV has raised an additional €10m to its series C financing bringing its amount to €45m.
Researchers from German Fraunhofer IGBI have used next-generation sequencing (NGS) to diagnosis sepsis from tiny amounts of microbial DNA in the blood.
The Innovative Medicines Initiative (IMI) has announced a €45m funding for the development of therapeutics and diagnostics to tackle coronavirus outbreaks.
With the financing led by General Atlantic, the British company wants to expand a novel platform and advance its ImmTAX pipeline to the clinic.
High amounts of injected vitamin C may delay the growth of many types of tumours and boost the anticancer power of immune checkpoint therapies, report Italian oncologists.